Clinical Trial Update: i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial [Phase 2]

View source ↗

Summary

This Phase 2 randomized, midazolam-controlled trial evaluates the combination of i-CBT and intravenous ketamine for suicidality in treatment-resistant depressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• Midazolam (Midazolam)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Major Depressive Disorder, Suicide | Phase 2 | Status: RECRUITING